湖北科技学院学报（医学版）

参考文献

[1]高兵.丹参的药理作用及临床应用分析[J].中国现代药物应用，2018,12(1):196

[2]REN Z H,TONG Y H,XU W,et al.Tanshinone ⅡA attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression[J].Phytomedicine,2010,17(3-4):212

[3]冯俊，李树生，陈华文.丹参酮ⅡA对压力超负荷心肌肥厚大鼠交感神经重构的影响[J].中国中医急症，2013,22(7):1087

[4]肖端，麦华超，叶文慧.丹参酮ⅡA对动脉粥样硬化家兔血管内皮功能和形态的保护作用[J].深圳中西医结合杂志，2017,27(19):20

[5]付丽.丹参酮ⅡA在粒细胞白血病中的抗肿瘤活性及其机制的研究[D].上海：上海师范大学，2020

[6]MAIONE F,PICCOLO M,DE VITA S,et al.Down regulation of proinflammatory pathways by tanshinone ⅡA and cryptotanshinone in a non-genetic mouse model of Alzheimer’s disease[J].Pharmacol Res,2018,129:482

[7]CHEN Y L,WU X M,YU S S,et al.Neuroprotection of Tanshinone ⅡA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats[J].PLoS One,2017,7(6):e40165

[8]侯道荣，刘振，崔斯童，等.丹参酮ⅡA通过调控TLR4/IκBα/NFκB信号通路抑制LPS诱导的细胞炎症[J].中国药理学通报，2021,37(2):210

[9]吕晓珮.丹参酮ⅡA对小鼠子宫内膜炎的抗炎作用及机制研究[D].青岛：青岛农业大学，2016

[10]俞小卫，高瑞辰，贺琛.丹参酮ⅡA磺酸钠对慢性支气管炎患者免疫因子及疗效的影响[J].实用临床医药杂志，2016,20(9):44

[11]李彩蓉，甘受益，黄红霞，等.丹参酮ⅡA磺酸钠治疗急性冠脉综合征的疗效及对炎症因子的影响[J].现代中西医结合杂志，2015,24(21):2284

[12]ZHANG M,CHEN Y,CHEN H,et al.Tanshinone ⅡA alleviates cardiac hypertrophy through m6A modification of galectin-3[J].Bioengineered,2022,13(2):4260

[13]TAN X,LI J,WANG X,et al.Tanshinone ⅡA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway[J].Int J Biol Sci,2011,7(3):383

[14]FENG J,CHEN H W,PI L J,et al.Protective effect of tanshinone ⅡA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway[J].Oncotarget,2017,8(6):10161

[15]CHEN Y F,LEE N H,PAI P Y,et al.Tanshinone-induced ERs suppresses IGFⅡ activation to alleviate Ang Ⅱ-mediated cardiac hypertrophy[J].J Recept Signal Transduct Res,2017,37(5):493

[16]OUYANG X,TAKAHADSHI K,KOMATSU K,et al.Protective effect of Salvia miltiorriza on angiotensin Ⅱ-induced hypertrophic responses in neonatal rat cardiol cells[J].Jpn J Pharmacol,2001,87(4):289

[17]GAO S,LIU Z,LI H,et al.Cardiovascular actions and therapeutic potential of tanshinone ⅡA.[J].Atherosclerosis,2012,220:3

[18]FANG Z Y,LIN R,YUAN B X,et al.Tanshinone ⅡA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet[J].Life Sci,2007,81(17):1339

[19]XU S,PETER J L,LAN T,et al.Tanshinone ⅡA attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet[J].Arch Biochem Biophys,2011,515(1-2):72

[20]罗炬辉，陈友权，何德全，等.丹参酮ⅡA对动脉粥样硬化C57小鼠血脂水平的影响观察[J].中国医药科学，2020,10(23):38

[21]王铁桥.丹参酮ⅡA对动脉粥样硬化的影响及其可能分子机制研究[D].中山：中山大学，2008

[22]姬郁林，何金涛，周清华，等.丹参酮对人肺癌细胞株的抑制作用及其分子机理[J].中国肺癌杂志，2008,11(2):201

[23]梁效功，羊裔明，邓承祺，等.丹参酮ⅡA诱导NB-4细胞凋亡时Caspase-3活性变化[J].四川大学学报(医学版),2003,34(3):549

[24]刘伟，陈昊.丹参酮ⅡA对人卵巢癌细胞株CAOV3增殖与凋亡的影响[J].医药导报，2007,26(12):1398

[25]杜睿，郑鸿，王艳萍，等.丹参酮ⅡA对人乳腺癌细胞株恶性表型逆转的研究[J].现代生物医学进展，2009,9(1):30

[26]方毅，宋光捷，陈黎，等.丹参酮ⅡA对阿尔茨海默症模型小鼠神经保护作用及对 PI3K/AKT通路的影响[J].中国实验动物学报，2021,29(4):499

[27]JADOON S S.丹参酮ⅡA对阿尔茨海默病的防治作用及机制研究[D].武汉：湖北中医药大学，2019

[28]JIANG P,LI C,XIANG Z,et al.Tanshinone ⅡA reduces the risk of Alzheimer's disease by inhibiting iNOS,MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease[J].Mol Med Report,2014,10(2):689

[29]LIU C,WU Y,ZHA S,et al.Treatment effects of tanshinone ⅡA against intracerebroventricular streptozotocin induced memory deficits in mice[J].Brain Res,2016,1631:137